Biospecifics Tech Cp (BSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,353 | 2,981 | 1,880 | 1,409 | 742 |
| Depreciation Amortization | 16 | -90 | 44 | 29 | 13 |
| Income taxes - deferred | 19 | 1,475 | 619 | 416 | 260 |
| Accounts receivable | 2,172 | -1,845 | 32 | 416 | 1,390 |
| Other Working Capital | 2,499 | -3,664 | -170 | 367 | 3,044 |
| Other Operating Activity | -2,146 | 2,074 | 171 | -241 | -1,350 |
| Operating Cash Flow | $3,914 | $930 | $2,575 | $2,397 | $4,100 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 157 | -120 | -190 | 0 | 0 |
| Purchase Sale Intangibles | N/A | N/A | -1,500 | -1,500 | -1,500 |
| Other Investing Activity | 0 | 0 | -1,500 | -1,500 | -1,500 |
| Investing Cash Flow | $157 | $-120 | $-1,690 | $-1,500 | $-1,500 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 148 | 148 | 78 | 78 |
| Common Stock Repurchased | -206 | -1,035 | -675 | -486 | -199 |
| Other Financing Activity | 0 | 263 | 268 | 102 | 102 |
| Financing Cash Flow | $-206 | $-624 | $-258 | $-306 | $-19 |
| Beginning Cash Position | 3,384 | 3,197 | 3,197 | 3,197 | 3,197 |
| End Cash Position | 7,248 | 3,384 | 3,824 | 3,788 | 5,778 |
| Net Cash Flow | $3,865 | $187 | $627 | $591 | $2,581 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,914 | 930 | 2,575 | 2,397 | 4,100 |
| Free Cash Flow | 3,914 | 930 | 2,575 | 2,397 | 4,100 |